Publications
HCCI’s external researcher publications powered by #HCCIdata

Sep
29

Kaiser Health News: Few Places Have More Medical Debt Than Dallas-Fort Worth, but Hospitals There Are Thriving

HCCI's Healthy Marketplace Index was cited in a KHN article on medical debt in Dallas-Fort Worth.  From the article: "Dallas-Fort Worth has the highest medical prices in Texas, according to the Health Care Cost Institute, a nonprofit that tracks costs nationwide. And in a state where most markets have relatively low medical prices, in-patient care at Dallas-Fort Worth hospitals was 13% more e...

Continue reading
Sep
21

September 2022 HCCI Research Highlights

 HCCI's data users and staff use our multi-payer, longitudinal commercial claims dataset to study some of the most pressing issues in the U.S. health care system. Here we highlight some recent research using HCCI data: New Study Shows Patients Paying More Out-of-Pocket Costs for Cancer Care | American Cancer Society A new, large study led by researchers at the American Cancer Society (ACS) an...

Continue reading
Tags:
Sep
20

Biosimilar Savings among People with Employer-Sponsored Insurance Not Keeping Pace with Savings in Medicare

Biologic drugs include a range of life-saving medications to treat cancer, diabetes, rheumatoid arthritis, retinal diseases, and many other conditions. Unlike "small molecule" drugs (e.g., statins), which can generally be taken at home, biologics are typically infusions or injections which require administration by a physician or other clinician in a hospital or physician's office. While just...

Continue reading
Sep
15

Kaiser Health News: Court Ruling May Spur Competitive Health Plans to Bring Back Copays for Preventive Services

HCCI's research on ESI spending on preventive services was featured in an article in Kaiser Health News. From the article: "Spending on ACA-mandated preventive services is relatively small but not insignificant. It is 2% to 3.5% of total annual expenditures by private employer health plans, or about $100 to $200 per person, according to the Health Care Cost Institute, a nonprofit research group." ...

Continue reading
Sep
14

Health Affairs: Giving A Buck Or Making A Buck? Donations By Pharmaceutical Manufacturers To Independent Patient Assistance Charities

Abstract The federal Anti-Kickback Statute prohibits biopharmaceutical manufacturers from directly covering Medicare enrollees' out-of-pocket spending for the drugs they manufacture, but manufacturers may donate to independent patient assistance charities and earmark donations for a condition treated by their drugs. To assess whether this law and its associated regulations prevent manufacturers fr...

Continue reading